Literature DB >> 17498854

Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles.

Juliano D Paccez1, Hoang D Nguyen, Wilson B Luiz, Rita C C Ferreira, Maria E Sbrogio-Almeida, Wolfgang Schuman, Luís C S Ferreira.   

Abstract

Recombinant Bacillus subtilis strains, either in the form of spores or vegetative cells, may be employed as safe and low-cost vaccine vehicles. In this study, we studied the role of promoter sequences and antigen-sorting signals on the immunogenicity based on previously constructed B. subtilis episomal expression systems. Mice orally immunized with spores or cells encoding the B subunit of the heat labile toxin (LTB), originally expressed by some enterotoxigenic Escherichia coli (ETEC) strains, under control of the stress-inducible gsiB promoter developed higher anti-LTB serum IgG and fecal IgA responses with regard to vaccine strains transformed with plasmids encoding the antigen under control of IPTG-inducible (Pspac) or constitutive (PlepA) promoters. Moreover, surface expression of the vaccine antigen under the control of the PgsiB promoter enhanced the immunogenicity of vegetative cells, while intracellular accumulation of LTB led to higher antibody responses in mice orally immunized with recombinant B. subtilis spores. Specific anti-LTB antibodies raised in vaccinated mice recognized and neutralized in vitro the native toxin produced by ETEC strains. Nonetheless, only mice orally immunized with recombinant B. subtilis strains, either as vegetative cells or spores, expressing intracellular LTB under the control of the gsiB promoter conferred partial protection to lethal challenges with purified LT. The present report further demonstrates that B. subtilis plasmid-based heterologous protein expression systems are adequate for antigen delivery via the oral route.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498854     DOI: 10.1016/j.vaccine.2007.04.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Using the IPTG-Inducible Pgrac212 Promoter for Overexpression of Human Rhinovirus 3C Protease Fusions in the Cytoplasm of Bacillus subtilis Cells.

Authors:  Vuong Duong Le; Trang Thi Phuong Phan; Tri Minh Nguyen; Luc Brunsveld; Wolfgang Schumann; Hoang Duc Nguyen
Journal:  Curr Microbiol       Date:  2019-10-14       Impact factor: 2.188

2.  Protective immunity against Eimeria tenella infection in chickens following oral immunization with Bacillus subtilis expressing Eimeria tenella 3-1E protein.

Authors:  Zhiwei Lin; Yanyun Shi; Bin Deng; Xiangfei Mao; Dongyou Yu; Weifen Li
Journal:  Parasitol Res       Date:  2015-05-22       Impact factor: 2.289

3.  Using an Agent-Based Model to Examine the Role of Dynamic Bacterial Virulence Potential in the Pathogenesis of Surgical Site Infection.

Authors:  Vissagan Gopalakrishnan; Moses Kim; Gary An
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-11       Impact factor: 4.730

4.  Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.

Authors:  Milene B Tavares; Bruno M Silva; Rafael C M Cavalcante; Renata D Souza; Wilson B Luiz; Juliano D Paccez; Paula J Crowley; L Jeannine Brady; Luís C S Ferreira; Rita C C Ferreira
Journal:  FEMS Immunol Med Microbiol       Date:  2010-03-10

5.  Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine.

Authors:  Gisela de Souza Pereira; Milene Tavares Batista; Nayara Fernanda Barros Dos Santos; Hélic Moreira Passos; Dalva Adelina da Silva; Ewerton Lucena Ferreira; Luís Carlos de Souza Ferreira; Rita de Cássia Café Ferreira
Journal:  Braz J Microbiol       Date:  2022-09-13       Impact factor: 2.214

6.  Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens.

Authors:  Milene Tavares Batista; Renata D Souza; Juliano D Paccez; Wilson B Luiz; Ewerton L Ferreira; Rafael C M Cavalcante; Rita C C Ferreira; Luís C S Ferreira
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

7.  Bacillus subtilis endospores at high purity and recovery yields: optimization of growth conditions and purification method.

Authors:  Milene B Tavares; Renata D Souza; Wilson B Luiz; Rafael C M Cavalcante; Caroline Casaroli; Eduardo G Martins; Rita C C Ferreira; Luís C S Ferreira
Journal:  Curr Microbiol       Date:  2012-11-27       Impact factor: 2.188

8.  Development of a Bacillus subtilis-based rotavirus vaccine.

Authors:  Sangun Lee; Boris R Belitsky; James P Brinker; Kathryn O Kerstein; David W Brown; John D Clements; Gerald T Keusch; Saul Tzipori; Abraham L Sonenshein; John E Herrmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

9.  Analysis and application of Bacillus subtilis sortases to anchor recombinant proteins on the cell wall.

Authors:  Hoang Duc Nguyen; Trang Thi Phuong Phan; Wolfgang Schumann
Journal:  AMB Express       Date:  2011-07-21       Impact factor: 3.298

Review 10.  Live bacterial vaccine vectors: an overview.

Authors:  Adilson José da Silva; Teresa Cristina Zangirolami; Maria Teresa Marques Novo-Mansur; Roberto de Campos Giordano; Elizabeth Angélica Leme Martins
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.